When Not to Use
- Type 1 Diabetes: EMPOLI 25mg Tablets are not suitable for the treatment of type 1 diabetes, which is insulin-dependent diabetes.
- Diabetic Ketoacidosis: This medication should not be used in individuals with diabetic ketoacidosis, a severe complication of diabetes characterized by high blood sugar levels and the presence of ketones in the urine.
- Severe Kidney Impairment or Dialysis: EMPOLI 25mg Tablets should not be used in individuals with severe kidney impairment or those undergoing dialysis.
- Allergy to Empagliflozin: Individuals with a known allergy to Empagliflozin or any components of EMPOLI 25mg Tablets should avoid using this medication.
Always follow your healthcare provider’s instructions for the correct dosage and frequency of EMPOLI 25mg Tablets. Regular monitoring of blood sugar levels and kidney function may be necessary during treatment. Inform your healthcare provider about any medical conditions you have or medications you are taking to ensure safe and effective use of Empagliflozin. If you experience any severe or persistent side effects, discontinue the use of EMPOLI 25mg Tablets and consult your healthcare provider for further evaluation. Empagliflozin is typically prescribed for short-term use and is not intended for long-term use without medical supervision.
Reviews
Clear filtersThere are no reviews yet.